Protocol for the study and treatment of Immune Thrombocytopenic Purpura (ITP). ITP-2010;Protocolo de estudio y tratamiento de la trombocitopenia inmune primaria (PTI-2010)

Anales de Pediatria

Volumn 74, Issue 6, 2011, Pages

  Monteagudo, E ^a   Fernandez Delgado R ^b   Sastre, A ^c   Toll, T ^d   Llort, A ^e   Molina, J ^f   Astigarraga, I ^g   Dasi M A ^a   Cervera, A ^h  

^a HOSPITAL INFANTIL LA FE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL INFANTIL LA PAZ   (Spain)

^d HOSPITAL SANT JOAN DE DÉU   (Spain)

^e HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

^f Universidad Pública de Navarra   (Spain)

^g HOSPITAL DE CRUCES   (Spain)

^h HOSPITAL DE MÓSTOLES   (Spain)

Author keywords

Children; Immune thrombocytopenic purpura; ITP; Primary immune thrombocytopenia

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CONSENSUS; DIAGNOSTIC PROCEDURE; HEALTH CARE ORGANIZATION; HEMATOLOGY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; ONCOLOGY; PRACTICE GUIDELINE; QUALITY OF LIFE;

CLINICAL PROTOCOLS; DECISION TREES; HUMANS; PURPURA, THROMBOCYTOPENIC;

EID: 79957915442     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2010.11.004     Document Type: Article

References (27)

1. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood. 2009;113:2386-93.
2. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168-86.
3. Kühne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR, Intercontinental Childhood ITP Study Group. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: An observational study. Lancet. 2001;358:2122-5.
4. Kühne T, Buchanan GR, Zimmerman S, Michaels LA, Kohan R, Berchtold W, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. J Pediatr. 2003;143:605-8. (Pubitemid 37452786)
5. Butros LJ, Bussel JB. Intracranial hemorrhage in immune thrombocytopenic purpura: A retrospective analysis. J Pediatr Hematol Oncol. 2003;25:660-4. (Pubitemid 36959433)
6. Iyori H, Bessho F, Ookawa H, Konishi S, Shirahata A, Miyazaki S, et al. Intracranial hemorrhage in children with immune thrombocytopenic purpura. Japanese study group on childhood ITP. Ann Hematol. 2000;79:691-5.
7. Medeiros D, Buchanan GR. Major hemorrhage in children with idiopathic thrombocytopenic purpura: Immediate response to therapy and long-term outcome. J Pediatr. 1998;133:334-9. (Pubitemid 28413613)
8. Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PH, Bennett CM, Neufeld EJ, et al. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008;112:4003-8.
9. Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB. Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): Study of 40 cases. Blood. 2009;114:4777-83.
10. Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, et al. Effects of eradication of helicobacter pylori infection in patients with immune thrombocytopenic purpura: A systematic review. Blood. 2009;113:1231-40.
11. Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-d, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet. 1994;344:703-7. (Pubitemid 24281420)
12. Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr. 1993;123:989-95. (Pubitemid 23353267)
13. Carcao MD, Zipursky A, Butchart S, Leaker M, Blanchette VS. Short-Course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl. 1998;424:71-4. (Pubitemid 28410866)
14. Adams DM, Kinney TR, O'Branski-Rupp E, Ware RE. High-Dose oral dexamethasone therapy for chronic childhood idiopathic thrombocytopenic purpura. J Pediatr. 1996;128:281-3. (Pubitemid 26065960)
15. Wali YA, Al Lamki Z, Shah W, Zacharia M, Hassan A. Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol. 2002;19:329-35. (Pubitemid 34633367)
16. Hedlund-Treutiger I, Henter JI, Elinder G. Randomized study of ivig and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003;25:139-44. (Pubitemid 36194042)
17. Ozsoylu S. Bolus methylprednisolone therapy in chronic idiopathic thrombocytopenic purpura in children. Acta Haematol. 1984;72:359. (Pubitemid 15155985)
18. Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, et al. Single dose of anti-d immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. J Pediatr. 2006;148:489-94.
19. Bussel JB, Kuter DJ, Pullarkat V, Lyons RM, Guo M, Nichol JL. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood. 2009;113:2161-71.
20. George JN, Mathias SD, Go RS, Guo M, Henry DH, Lyons R, et al. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: Results from two randomized, placebo-controlled trials. Br J Haematol. 2009;144:409-15.
21. Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, et al. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med. 2006;355:1672-81. (Pubitemid 44583957)
22. Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomised controlled trial. Lancet. 2008;371:395-403. (Pubitemid 351181334)
23. Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: A randomised, double-blind, placebo-controlled trial. Lancet. 2009;373:641-8.
24. García-Chávez J, Majluf-Cruz A, Montiel-Cervantes L, Esparza MG, Vela-Ojeda J, Mexican Hematology Study Group. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: A long-term follow-up analysis. Ann Hematol. 2007;86:871-7.
25. Parodi E, Rivetti E, Amendola G, Bisogno G, Calabrese R, Farruggia P, et al. Long-Term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: Identification of factors predictive of a sustained response. Br J Haematol. 2009;144:552-8.
26. Bennett CM, Rogers ZR, Kinnamon DD, Bussel JB, Mahoney DH, Abshire TC, et al. Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood. 2006;107:2639-42.
27. Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in hiv-negative patients: A report of 57 cases from the research on adverse drug events and reports project. Blood. 2009;113:4834-40.